Sign In
19 Jun 2013 09:59
19 June 2013
TYRATECH, INC.
("TyraTech" or the "Company")
Blocklisting Interim Review
TyraTech, Inc. (AIM: TYR), a natural life sciences company, provides the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules:
Name of company: | TyraTech, Inc.
|
Name of scheme: | 2007 Equity Compensation Plan of the Company
|
Period of return: | From: 17 December 2012 To: 18 June 2013
|
Number and class of securities not issued under the scheme | 5,164,996 common shares
|
Number of securities issued under the scheme during the period | Nil
|
Balance under the scheme of securities not yet issued at the end of the period | 5,164,996 common shares
|
Number and class of securities originally admitted and the date of admission | 5,183,746 common shares on 2 March 2011
|
Name of contact: | Daniel Williams
|
Telephone number of contact: | +1 919 415 4285 |
For further information please contact:
TyraTech Inc.Alan Reade, Executive ChairmanTel: +1 919 415 4310
Bruno Jactel, Chief Executive Officer
Tel: +1 919 415 4280
N+1 Singer, Nominated Adviser and Joint BrokerAubrey Powell / Alex WrightTel: +44 20 7496 3000
First Columbus LLP, Joint BrokerChris CrawfordTel: +44 20 3002 2070
Walbrook, Financial PR and IR
Bob Huxford /Helen Westaway (Public Relations)
Tel + 44 7933 8792
Paul Cornelius (Investor Relations)
Tel +44 20 7933 8794
Follow the stocks
